"Official medicines" is the best online drugstore.

World’s leading meds delivered to your door – and you don’t even need a prescription! Only certified, first class drugs on offer! Buy more and spend less with our great discount system.

The meds you need, reliable and hassle free! Top products of top brands.

The only pharmacy shop you will ever need! Approved drugs available without prescription. Best deals, unmatched service and shipping. 100% safe!


(PAN-cue-ROW-nee-uhm BROE-mide)
Pavulon
Class: Nondepolarizing neuromuscular blocker

 Action Binds competitively to cholinergic receptors on motor end-plate to antagonize action of acetylcholine, resulting in block of neuromuscular transmission.

 Indications Adjunct to general anesthesia for induction of skeletal muscle relaxation; facilitation of management of patients undergoing mechanical ventilation; facilitation of tracheal intubation.

 Contraindications Hypersensitivity to bromides.

 Route/Dosage

Surgical Procedures

ADULTS & CHILDREN > 1 MO: IV 0.04 to 0.1 mg/kg initially. Maintenance: Use incremental doses q 25 to 60 min beginning with 0.01 mg/kg. NEONATES (< 1 MO): IV Test dose: 0.02 mg/kg.

Endotracheal Intubation

ADULTS & CHILDREN: IV 0.06 to 0.1 mg/kg. NEONATES: IV Test dose: 0.02 mg/kg.

 Interactions

Aminoglycosides, bacitracin, clindamycin, colymycin, polymyxin B, inhalational anesthetics, ketamine, lincomycin, magnesium salts, quinidine, quinine, succinylcholine, vancomycin: May augment action of pancuronium. Azathioprine, mercaptopurine: May cause reversal of neuromuscular blocking effects of pancuronium. Carbamazepine, hydantoins: May decrease duration and effect of pancuronium. Theophyllines: May cause possible resistance to, or reversal of, effects of pancuronium; cardiac arrhythmias may occur. Trimethaphan: May cause prolonged apnea.

 Lab Test Interferences None well documented.

 Adverse Reactions

CV: Tachycardia; elevated BP. DERM: Transient rash. GI: Salivation. RESP: Respiratory insufficiency; apnea. OTHER: Skeletal muscle weakness to complete relaxation; hypersensitivity reactions (eg, bronchospasm, flushing, redness, hypotension, tachycardia).

 Precautions

Pregnancy: Category C; do not use in early pregnancy. Labor: Reduce dosage in cesarean section if patient is receiving magnesium sulfate. Children: Prolonged use in neonates undergoing mechanical ventilation has been associated with severe skeletal muscle weakness and methemoglobinemia. Altered circulation time (eg, elderly patients, patients with CV disease or edema): Delay in onset of action. Electrolyte imbalance: Neuromuscular blockade may be altered depending on nature of imbalance. Hepatic or biliary tract disease: Results in slower onset and prolonged duration. Myasthenia gravis: Small doses may have profound effects. Obesity/Neuromuscular disease: Require special attention to airway maintenance and ventilatory support. Pain/Anxiety: Pancuronium does not have analgesic or antianxiety effects. Paralyzed patient will still need analgesic or sedative agents if indicated. Renal disease: Renally excreted; may require lower doses or less frequent maintenance doses.

PATIENT CARE CONSIDERATIONS

 Administration/Storage

  • May be diluted in 0.9% Sodium Chloride, D5W, 5% Dextrose and Sodium Chloride, and Lactated Ringer’s solution.
  • Have entratracheal equipment, oxygen, suction equipment, and mechanical ventilator available for respiratory support.
  • Diluted solution is stable for 48 hr at room temperature.
  • Store undiluted product in refrigerator (potency maintained for 2 yr) or at room temperature (potency maintained for 6 mo).

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • If patient has myasthenia gravis, small test dose must be administered and patient’s response to administration of muscle relaxant must be monitored.
  • Provide total care for immobilized patient.
  • Turn patient and perform chest physiotherapy q 2 hr.
  • Assess I&O.
  • Check mechanical ventilator settings often.
  • Monitor respiratory status closely and notify physician if changes occur. Auscultate breath sounds to detect wheezes or crackles.
  • Monitor vital signs frequently during therapy to detect cardiovascular reactions.
  • If respiratory status changes, notify physician.
  • If respiratory secretions develop, perform suction.
  • If electrolytes and blood gases deteriorate, notify physician immediately.
OVERDOSAGE: SIGNS & SYMPTOMS
  Skeletal muscle relaxation, decreased respiratory reserve, low tidal volume, apnea, prolonged neuromuscular blockade

 Patient/Family Education

  • Reassure patient and family that breathing will return to normal after pancuronium is discontinued.
  • Maintain calm environment, provide reassurance regularly, and explain all procedures to patient and family.

Popularity: 1% [?]


If you're still unable to find appropriate information in the article, please use search form below